Ophthalmology · Torrance, CA
NPI
1750356754
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
21840 Normandie Ave, Ste. 700
Torrance, CA, 90502
Phone (310) 222-5101
Groups this clinician bills Medicare through
Medicare paid, 2024
$196K
2,955 services
Medicare patients, 2024
421
Average age 73
Drug cost, 2024
$987K
3,375 prescriptions
Company payments, 2025
$654
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawrence T Goodwin Jr. was code 92012 (ophthalmological e&m), 1,318 times for 346 patients. In total Lawrence T Goodwin Jr. billed 2,955 services in 40 codes, and Medicare paid $196K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 1,318 | 346 | $75.83 | $100K |
| 92083 Vision, Hearing, and Speech Services | Office | 351 | 172 | $27.96 | $9,812 |
| 92250 Angiography | Office | 324 | 159 | $15.92 | $5,159 |
| 92133 Computerized Ophthalmic Imaging | Office | 322 | 161 | $15.41 | $4,962 |
| 92014 Ophthalmological E&M | Office | 94 | 94 | $102.05 | $9,593 |
| 92132 Computerized Ophthalmic Imaging | Office | 94 | 38 | $13.64 | $1,282 |
| 76519 Ultrasound - Nonspecific | Office | 75 | 36 | $30.24 | $2,268 |
| 92004 Ophthalmological E&M | Office | 62 | 62 | $114.57 | $7,103 |
| 92202 Ophthalmological E&M | Office | 41 | 41 | $13.45 | $552 |
| 99214 Office E&M - Established | Office | 32 | 29 | $101.86 | $3,260 |
| 92020 Ophthalmological E&M | Office | 25 | 25 | $20.81 | $520 |
| 66984 Cataract Surgery | Facility | 25 | 22 | $478.76 | $12K |
| 66821 Cataract Surgery | Office | 24 | 20 | $287.23 | $6,893 |
| 99204 Office E&M - New | Office | 15 | 15 | $137.18 | $2,058 |
By year: 2022 $358K for 3,620 services; 2023 $380K for 3,487 services; 2024 $196K for 2,955 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lawrence T Goodwin Jr. prescribed most often to Medicare patients was Latanoprost, with 671 prescriptions and refills. In total Lawrence T Goodwin Jr. wrote 3,375 Medicare prescriptions that cost $987K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 671 | 1,275 | 187 | $7,104 |
| Prednisolone Acetate Generic | 563 | 660 | 242 | $29K |
| Cyclosporine Generic | 233 | 317 | 81 | $69K |
| Methazolamide Generic | 211 | 312 | 51 | $49K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 206 | 215 | 103 | $1,994 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 197 | 394 | 68 | $3,212 |
| Ciprofloxacin Hcl Generic | 183 | 206 | 106 | $3,225 |
| Brimonidine Tartrate Generic | 173 | 297 | 45 | $13K |
| Timolol Maleate Generic | 140 | 256 | 39 | $1,969 |
| Ketorolac Tromethamine Generic | 130 | 187 | 73 | $2,650 |
| Restasis Cyclosporine | 94 | 130 | 32 | $76K |
| Restasis Multidose Cyclosporine | 80 | 126 | 29 | $80K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 59 | 87 | 18 | $9,897 |
| Lumigan Bimatoprost | 53 | 89 | 18 | $25K |
| Acetazolamide Er Acetazolamide | 43 | 83 | 18 | $4,030 |
Brand drugs: 1,777 claims; generic drugs: 1,598 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawrence T Goodwin Jr. $654 ($654 in general payments such as food, travel and fees) from 7 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $236.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 9 | $236 |
| Mallinckrodt Hospital Products Inc. | 5 | $146 |
| Alcon Vision LLC ALC | 4 | $127 |
| Amgen Inc. AMGN | 3 | $73.6 |
| Dompe US, Inc. | 1 | $35.31 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $20.04 |
| LKC Technologies, Inc. | 1 | $15.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.